IBDEI15K ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18710,2)
 ;;=^5015556
 ;;^UTILITY(U,$J,358.3,18711,0)
 ;;=N06.1^^64^837^14
 ;;^UTILITY(U,$J,358.3,18711,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18711,1,3,0)
 ;;=3^Isolated Proteinuria w/ Focal/Segmental Glomerular Lesions
 ;;^UTILITY(U,$J,358.3,18711,1,4,0)
 ;;=4^N06.1
 ;;^UTILITY(U,$J,358.3,18711,2)
 ;;=^5015550
 ;;^UTILITY(U,$J,358.3,18712,0)
 ;;=N06.0^^64^837^15
 ;;^UTILITY(U,$J,358.3,18712,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18712,1,3,0)
 ;;=3^Isolated Proteinuria w/ Minor Glomerular Abnormality
 ;;^UTILITY(U,$J,358.3,18712,1,4,0)
 ;;=4^N06.0
 ;;^UTILITY(U,$J,358.3,18712,2)
 ;;=^5015549
 ;;^UTILITY(U,$J,358.3,18713,0)
 ;;=N06.8^^64^837^16
 ;;^UTILITY(U,$J,358.3,18713,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18713,1,3,0)
 ;;=3^Isolated Proteinuria w/ Morphologic Lesion
 ;;^UTILITY(U,$J,358.3,18713,1,4,0)
 ;;=4^N06.8
 ;;^UTILITY(U,$J,358.3,18713,2)
 ;;=^5015557
 ;;^UTILITY(U,$J,358.3,18714,0)
 ;;=N14.3^^64^837^25
 ;;^UTILITY(U,$J,358.3,18714,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18714,1,3,0)
 ;;=3^Nephropathy Induced by Heavy Metals
 ;;^UTILITY(U,$J,358.3,18714,1,4,0)
 ;;=4^N14.3
 ;;^UTILITY(U,$J,358.3,18714,2)
 ;;=^5015593
 ;;^UTILITY(U,$J,358.3,18715,0)
 ;;=N14.1^^64^837^24
 ;;^UTILITY(U,$J,358.3,18715,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18715,1,3,0)
 ;;=3^Nephropathy Induced by Drug/Meds/Biol Subst
 ;;^UTILITY(U,$J,358.3,18715,1,4,0)
 ;;=4^N14.1
 ;;^UTILITY(U,$J,358.3,18715,2)
 ;;=^5015591
 ;;^UTILITY(U,$J,358.3,18716,0)
 ;;=N29.^^64^837^17
 ;;^UTILITY(U,$J,358.3,18716,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18716,1,3,0)
 ;;=3^Kidney and Ureter Disorders in Diseases Classd Elsewhr
 ;;^UTILITY(U,$J,358.3,18716,1,4,0)
 ;;=4^N29.
 ;;^UTILITY(U,$J,358.3,18716,2)
 ;;=^5015631
 ;;^UTILITY(U,$J,358.3,18717,0)
 ;;=N15.8^^64^837^26
 ;;^UTILITY(U,$J,358.3,18717,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18717,1,3,0)
 ;;=3^Renal Tubulo-Interstitial Diseases
 ;;^UTILITY(U,$J,358.3,18717,1,4,0)
 ;;=4^N15.8
 ;;^UTILITY(U,$J,358.3,18717,2)
 ;;=^5015595
 ;;^UTILITY(U,$J,358.3,18718,0)
 ;;=N14.4^^64^837^27
 ;;^UTILITY(U,$J,358.3,18718,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18718,1,3,0)
 ;;=3^Toxic Nephropathy NEC
 ;;^UTILITY(U,$J,358.3,18718,1,4,0)
 ;;=4^N14.4
 ;;^UTILITY(U,$J,358.3,18718,2)
 ;;=^5015594
 ;;^UTILITY(U,$J,358.3,18719,0)
 ;;=N05.6^^64^837^19
 ;;^UTILITY(U,$J,358.3,18719,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18719,1,3,0)
 ;;=3^Nephritic Syndrome w/ Dense Deposit Disease,Unspec
 ;;^UTILITY(U,$J,358.3,18719,1,4,0)
 ;;=4^N05.6
 ;;^UTILITY(U,$J,358.3,18719,2)
 ;;=^5015547
 ;;^UTILITY(U,$J,358.3,18720,0)
 ;;=N05.7^^64^837^20
 ;;^UTILITY(U,$J,358.3,18720,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18720,1,3,0)
 ;;=3^Nephritic Syndrome w/ Diffuse Crescentic Glomerulonephritis,Unspec
 ;;^UTILITY(U,$J,358.3,18720,1,4,0)
 ;;=4^N05.7
 ;;^UTILITY(U,$J,358.3,18720,2)
 ;;=^5015548
 ;;^UTILITY(U,$J,358.3,18721,0)
 ;;=N05.1^^64^837^21
 ;;^UTILITY(U,$J,358.3,18721,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18721,1,3,0)
 ;;=3^Nephritic Syndrome w/ Focal/Segmental Glomerular Lesions,Unspec
 ;;^UTILITY(U,$J,358.3,18721,1,4,0)
 ;;=4^N05.1
 ;;^UTILITY(U,$J,358.3,18721,2)
 ;;=^5015542
 ;;^UTILITY(U,$J,358.3,18722,0)
 ;;=N05.0^^64^837^22
 ;;^UTILITY(U,$J,358.3,18722,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18722,1,3,0)
 ;;=3^Nephritic Syndrome w/ Minor Glomerular Abnormality,Unspec
